Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carson

Showing results (281-290 of 364) with videos related to

Pageof 37
Sort By:
The British Journal of Dermatology|August 24, 2021
Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case seriesN A Trum, J Zain, X U Martinez, et al.
Transactions of the Association of American Physicians|January 1, 1990
Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardiumH F Weisman, T Bartow, M K Leppo, et al.
JMIR Mhealth and Uhealth|October 23, 2025
Hybrid Health IT and Telehealth-Delivered Behavioral Weight Loss Services for Primary Care Patients With Cardiovascular Risk Factors: Intervention Component Design and Pragmatic Randomized Feasibility TrialRonald T Ackermann, Kenzie A Cameron, David T Liss, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N,N-dialkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, potent, selective delta opioid agonistsJohn R Carson, Steven J Coats, Ellen E Codd, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Synthesis and structure--activity relationships of aroylpyrrole alkylamide bradykinin (B2) antagonistsMark A Youngman, John R Carson, Jung S Lee, et al.
Journal of Medicinal Chemistry|May 23, 1997
Aroyl(aminoacyl)pyrroles, a new class of anticonvulsant agentsJ R Carson, R J Carmosin, P M Pitis, et al.
Journal of Strength and Conditioning Research|August 28, 2014
Caloric expenditure of aerobic, resistance, or combined high-intensity interval training using a hydraulic resistance system in healthy menPaul H Falcone, Chih-Yin Tai, Laura R Carson, et al.
Computer Methods and Programs in Biomedicine|August 13, 1998
Preliminary experience of the DIAS computer model in providing insulin dose advice to patients with insulin dependent diabetesD A Cavan, O K Hejlesen, R Hovorka, et al.
JAMA Network Open|October 29, 2020
Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid TumorsChangxia Shao, Gerald Li, Lingkang Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2020
Corrections to "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma"A M Evens, K R Carson, J Kolesar, et al.
Pageof 37

Showing results (281-290 of 364) with videos related to

Sort By:
Pageof 37
The British Journal of Dermatology|August 24, 2021
Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case seriesN A Trum, J Zain, X U Martinez, et al.
Transactions of the Association of American Physicians|January 1, 1990
Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardiumH F Weisman, T Bartow, M K Leppo, et al.
JMIR Mhealth and Uhealth|October 23, 2025
Hybrid Health IT and Telehealth-Delivered Behavioral Weight Loss Services for Primary Care Patients With Cardiovascular Risk Factors: Intervention Component Design and Pragmatic Randomized Feasibility TrialRonald T Ackermann, Kenzie A Cameron, David T Liss, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N,N-dialkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, potent, selective delta opioid agonistsJohn R Carson, Steven J Coats, Ellen E Codd, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Synthesis and structure--activity relationships of aroylpyrrole alkylamide bradykinin (B2) antagonistsMark A Youngman, John R Carson, Jung S Lee, et al.
Journal of Medicinal Chemistry|May 23, 1997
Aroyl(aminoacyl)pyrroles, a new class of anticonvulsant agentsJ R Carson, R J Carmosin, P M Pitis, et al.
Journal of Strength and Conditioning Research|August 28, 2014
Caloric expenditure of aerobic, resistance, or combined high-intensity interval training using a hydraulic resistance system in healthy menPaul H Falcone, Chih-Yin Tai, Laura R Carson, et al.
Computer Methods and Programs in Biomedicine|August 13, 1998
Preliminary experience of the DIAS computer model in providing insulin dose advice to patients with insulin dependent diabetesD A Cavan, O K Hejlesen, R Hovorka, et al.
JAMA Network Open|October 29, 2020
Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid TumorsChangxia Shao, Gerald Li, Lingkang Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2020
Corrections to "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma"A M Evens, K R Carson, J Kolesar, et al.
Pageof 37